Interaction Checker

Interacciones de Ertapenem

Ertapenem (Invanz), antibiótico, tiene 75 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 48; moderadas: 27; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (48)

  • Ácido valproicoanticonvulsivoGrave

    The concomitant use of ertapenem and valproic acid/divalproex sodium is generally not recommended. (etiqueta de Ertapenem, Advertencias y precauciones)

  • Amoxicilinaantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Amoxicilina y ácido clavulánicoantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Ampicilinaantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Ampicilina y sulbactamantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Articaína y adrenalinaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Bupivacaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Bupivacaína y adrenalinaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • CefaclorcefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefadroxilocefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefalexinacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefazolinacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefdinircefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefepimacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefiximacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefotaximacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefotetáncefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefoxitinacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefpodoximacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefprozilocefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CeftarolinacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CeftazidimacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CeftriaxonacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • CefuroximacefalosporinaGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Cloroprocaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Cocaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Desfluranoanestésico generalGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Dicloxacilinaantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Divalproato de sodio (valproato)anticonvulsivoGrave

    The concomitant use of ertapenem and valproic acid/divalproex sodium is generally not recommended. (etiqueta de Ertapenem, Advertencias y precauciones)

  • Etomidatoanestésico generalGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Isofluranoanestésico generalGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Ketaminadepresor del SNCGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Lidocaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Lidocaína y adrenalinaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Lidocaína y prilocaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Mepivacaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • MetohexitalbarbitúricoGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Nafcilinaantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Oxacilinaantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Penicilina Gantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Penicilina Vantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Piperacilina y tazobactamantibiótico del grupo de las penicilinasGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Prilocaína y adrenalinaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • ProbenecidGrave

    Co-administration with probenecid inhibits the renal excretion of ertapenem and is therefore not recommended. (etiqueta de Ertapenem, Interacciones medicamentosas)

  • Probenecid y colchicinaGrave

    Co-administration with probenecid inhibits the renal excretion of ertapenem and is therefore not recommended. (etiqueta de Ertapenem, Interacciones medicamentosas)

  • Propofoldepresor del SNCGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Ropivacaínaanestésico localGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

  • Sevofluranoanestésico generalGrave

    Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type. (etiqueta de Ertapenem, Contraindicaciones)

Interacciones moderadas (27)

  • BrivaracetamanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • Cannabidiol (con receta)anticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • CarbamazepinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • CenobamatoanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • ClobazambenzodiazepinaModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • ClonazepambenzodiazepinaModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • EslicarbazepinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • EtosuximidaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • FelbamatoanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • FenitoínaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • FenobarbitalbarbitúricoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • Fentermina y topiramatoestimulante del SNCModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • FosfenitoínaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • GabapentinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • LacosamidaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • LamotriginaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • LevetiracetamanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • MesuximidaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • OxcarbazepinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • PerampanelanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • PregabalinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • PrimidonaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • RufinamidaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • TiagabinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • TopiramatoanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • VigabatrinaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

  • ZonisamidaanticonvulsivoModerada

    If focal tremors, myoclonus, or seizures occur, patients should be evaluated neurologically, placed on anticonvulsant therapy if not already instituted, and the dosage of INVANZ re-examined to determine whether it should be decreased or discontinued. (etiqueta de Ertapenem, Advertencias y precauciones)

Compruebe Ertapenem frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.